Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of stromal sarcoma with multiple local recurrences]Eriko Murakami, Katsuhisa Enomoto, Kenichi Sakurai, et al.
BMJ Open|December 14, 2019
Furosemide versus mannitol in Japanese patients with thoracic malignancy who received cisplatin-based chemotherapy using short hydration: study protocol for a randomised controlled trialEriko Murakami, Hiroaki Akamatsu, Toshio Shimokawa, et al.
Respirology Case Reports|September 2, 2024
Unsuccessful rechallenge with nivolumab in a patient with advanced non-small cell lung cancer who had a 6-year complete response and treatment-free period: Case reportToshiaki Takakura, Hiroaki Akamatsu, Atsushi Washioka, et al.
Biological & Pharmaceutical Bulletin|May 8, 2019
Feasibility of Trypsin Digestion as a Sample Preparation for Daptomycin Quantification in Murine Skeletal MusclesYusuke Sakai, Eriko Murakami, Hideo Kato, et al.
Translational Lung Cancer Research|December 13, 2024
Invasive mucinous adenocarcinoma harbored MET exon 14 skipping mutation: case reportAtsushi Washioka, Hiroaki Akamatsu, Takeya Sugimoto, et al.
Chemotherapy|November 14, 2017
Considerations about the Use of a Loading Dose of Daptomycin in a Neutropenic Murine Thigh Infection Model with Methicillin-Resistant Staphylococcus aureus InfectionHideo Kato, Mao Hagihara, Eriko Murakami, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|February 1, 2005
[A case of pityriasis rubra pilaris associated with rapidly progressive finger joint destruction]Hirokazu Ohashi, Hiroki Takahashi, Mikiko Obara, et al.
Acta Histochemica Et Cytochemica|December 6, 2016
Roles of Ras Homolog A in Invasive Ductal Breast CarcinomaEriko Murakami, Yoko Nakanishi, Yukari Hirotani, et al.
Cancer Science|January 6, 2015
Altered intracellular region of MUC1 and disrupted correlation of polarity-related molecules in breast cancer subtypesMisato Iizuka, Yoko Nakanishi, Fumi Fuchinoue, et al.
Anticancer Research|January 31, 2021
Phase Ib Study of Osimertinib Plus Ramucirumab in Japanese Lung Cancer Patients With EGFR MutationHiroaki Akamatsu, Yuichi Ozawa, Jun Oyanagi, et al.
Pageof 2